RA Capital Management - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 1 filers reported holding AKARI THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2016$714,000
-26.4%
101,439
-11.0%
0.10%
+1.0%
Q3 2016$970,000
-69.3%
114,039
-51.3%
0.10%
-77.2%
Q2 2016$3,160,000
+21.6%
234,240
-9.1%
0.44%
+31.9%
Q1 2016$2,598,000
-32.1%
257,721
-2.3%
0.33%
-12.4%
Q4 2015$3,827,000
-39.6%
263,9210.0%0.38%
-58.4%
Q3 2015$6,333,000263,9210.91%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders